Activation of STAT3 signaling in human stomach adenocarcinoma drug-resistant cell line and its relationship with expression of vascular endothelial growth factor

World Journal of Gastroenterology

Volumn 11, Issue 6, 2005, Pages 875-879

  Yu, Li Fen ^a   Cheng, Ying ^a   Qiao, Min Min ^a   Zhang, Yong Ping ^a   Wu, Yun Lin ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Antineoplastic Drug Resistance; STAT3 protein; Stomach adenocarcinoma; Vascular endothelial growth factor

Indexed keywords

FLUOROURACIL; MESSENGER RNA; STAT3 PROTEIN; VASCULOTROPIN;

ARTICLE; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; WESTERN BLOTTING;

EID: 14544278383     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i6.875     Document Type: Article

References (30)

1. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000; 19: 2474-2488
2. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE Jr. STAT3 as an oncogene. Cell 1999; 98: 295-303
3. Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y, Kim JD. Constitutive activation of STAT3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci USA 2000; 97: 4227-4232
4. Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R, Li Y, Wang JM, Yang-Yen HF, Karras J, Jove R, Loughran TP Jr. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Investig 2001; 107: 351-362
5. Bowman T, Broome MA, Sinibaldi D, Wharton W, Pledger WJ, Sedivy JM, Irby R, Yeatman T, Courtneidge SA, Jove R. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci USA 2001; 98: 7319-7324
6. Matsui T, Kinoshita T, Hirano T, Yokota T, Miyajima A. STAT3 down-regulates the expression of cyclin D during liver development. J Biol Chem 2002; 277: 36167-36173
7. Yahata Y, Shirakata Y, Tokumaru S, Yamasaki K, Sayama K, Hanakawa Y, Detmar M, Hashimoto K. Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation. J Biol Chem 2001; 278: 40026-40031
8. Bartoli M, Platt D, Lemtalsi T, Gu X, Brooks SE, Marrero MB, Caldwell RB. VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J 2003; 17: 1562-1564
9. Laird AD, Li G, Moss KG, Blake RA, Broome MA, Cherrington JM, Mendel DB. Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and - independent growth of human tumor cells. Mol Cancer Ther 2003; 2: 461-469
10. Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, Hsieh CY. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 2003; 22: 1517-1527
11. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. Constitutive STAT3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002; 21: 2000-2008
12. Lu M, Jiang Y, Wang R. The relationship of vascular endothelial growth factor and angiogenesis to the progression of gastric carcinoma. Zhonghua Binglixue Zazhi 1998; 27: 278-281
13. Erenoglu C, Akin ML, Uluutku H, Tezcan L, Yildirim S, Batkin A. Angiogenesis predicts poor prognosis in gastric carcinoma. Dig Surg 2000; 17: 581-586
14. Maehara Y, Kabashima A, Koga T, Tokunaga E, Takeuchi H, Kakeji Y, Sugimachi K. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery 2000; 128: 408-416
15. Bomberg J, Darnell JE Jr. The role of STATs in transcriptional control and their impact on cellular FUnction. Oncogne 2000; 19: 2468-2473
16. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS, Jove R. Constitutive activation of STAT3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999; 10: 105-115
17. Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 2002; 8: 945-954
18. Ying C, Yunlin W, Yongping Z, Jie Z. Studies on drug resistance mechanisms to 5-fluorouracil in human gastric cancer cell lines. Tumor J World 2003; 2: 192-195
19. Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K. STAT3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 2003; 22: 319-329
20. Shuai K. Modulation of STAT signaling by STAT-interacting proteins. Oncogene 2000; 19: 2638-2644
21. Greenhalgh CJ, Hilton DJ. Negative regulation of cytokine signaling. J Leukocyte Biol 2001; 70: 348-356
22. Starr R, Hilton DJ. Negative regulation of the JAK/STAT pathway. Bioessays 1999; 21: 47-52
23. Cooney RN. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock 2002; 17: 83-90
24. Krebs DL, Hilton DJ. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 2001; 19: 378-387
25. Ilangumaran S, Rottapel R. Regulation of cytokine receptor signaling by SOCS1. Immunol Rev 2003; 192: 196-211
26. Frantsve J, Schwaller J, Sternberg DW, Kutok J, Gilliland DG. Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol Cell Biol 2001; 21: 3547-3557
27. Koyama M, Nagai H, Bando K, Ito M, Moriyama Y, Emi M. Localization of a target region of allelic loss to a 1-cM interval on chromosome 16p.13.13 in hepatocellular carcinoma. Jpn J Cancer Res 1999; 90: 951-956
28. Marine JC, McKay C, Wang D, Topham DJ, Parganas E, Nakajima H, Pendeville H, Yasukawa H, Sasaki A, Yoshimura A, Ihle JN. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell 1999; 98: 617-627
29. Wormald S, Hilton DJ. Inhibitors of cytokine signal transduction. J Biol Chem 2004; 279: 821-824
30. Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K. Specific inhibition of STAT3 signal transduction by PIAS3. Science 1997; 278: 1803-1805